AMERICAN CANNABIS CO. - Wkn: A12DK9 - Aktie
Seite 16 von 37 Neuester Beitrag: 24.04.21 23:22 | ||||
Eröffnet am: | 16.09.15 16:00 | von: youmake222 | Anzahl Beiträge: | 906 |
Neuester Beitrag: | 24.04.21 23:22 | von: Leahjnima | Leser gesamt: | 266.164 |
Forum: | Hot-Stocks | Leser heute: | 81 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 13 | 14 | 15 | | 17 | 18 | 19 | ... 37 > |
Wird an 2 deutschen Börsen gehandelt ( + Can + USA ) Dripple-Listing.
Ihr denkt ich rede Blödsinn ?? Mal abwarten - so schnell wie der Markt nun nach unten
übertrieben ( Luft rausgelassen ) hat , so schnell geht etz wieder rauf. Strong Buy AMMJ.
Und : FINORE grad 35 % Plus - Klasse !!
Einstieg grad richtig gemacht gestern :-)
Einmal mehr bewiesen warum die Aktie so beliebt ist, hoffe niemand ist in den letzten Tagen mit Verlust ausgestiegen.
Hab habe die Rutsche gleich am Anfang genutzt und noch welche zu 0,57 € eingesackt ( leider etwas früh, hätte sie etwas später auch kurz für 0,50 € bekommen).
Sollten wir nächste Woche nochmal runter rutschen (was ich nicht glaube) , dann hol ich mir 5K als tradingposition. Das ja im Moment der reinste Tradertraum hier :-)
Indoor flower spanned from $1,000 to $3,200 per pound; the median price was $1,800.
Greenhouse flower spanned from $900 to $2,400 per pound; the median price was $1,700.
Outdoor flower spanned from $800 to $2,300 per pound; the median price was $1,350........
Though pricing for greenhouse-grown flower jumped almost 6% week-over-week, declines in rates for indoor and outdoor product - which this week combined to make up almost 85% of the total observed volume traded - pushed down the composite volume-weighted average. National pricing for indoor product nearly reached the $1,800 per pound threshold. Prices for outdoor flower continue to fall, but the pace of the decline has slowed in recent ......
.... reaching annual lows were observed this week, for indoor product in Michigan, as well as nationally......The gap between medical and recreational prices contracted dramatically this week to only $40, from last week’s difference of $163. Prices rose in the adult-use markets of Colorado, Washington, and Oregon - with the most significant rise taking place in the latter state - pushing composite rates for adult-use product up over 5% compared to last week. Contrastingly, an overall fall in prices in California’s medical market largely drove the decline in pricing for such product. The current difference between rates for flower of each designation is the smallest since we have begun publishing this metric and was anticipated in light of low harvest season pricing in California, the nation’s largest legal market of any type by a significant measure." ENde Zitat
Source:https://www.cannabisbenchmarks.com/weekly-report.html
§
Zitat:"December 2016 Forward unchanged at $1,525 per pound.
The share of forward transactions observed represented 4.6% of all reported deals, and were priced similarly to last week. 100% of reported forwards had durations of at least 3 months. At $1,525 per pound, the December Forward represents a premium of 10% relative to the current U.S. Spot Index of $1,386.....
For context, in 2015, the U.S. Spot Index experienced an average price increase of 7% from November (at $1,801 per pound) to December (at $1,927 per pound). In absolute terms, the difference was $126 per pound, versus the current Spot to December 2016 Forward differential of $139 per pound.......
The average forward deal was 30 pounds. The proportion of forward deals for outdoor, greenhouse and indoor grown flower represented 38%, 31% and 31% of forward arrangements, respectively, unchanged from last week. The median forward deal size for monthly delivery for outdoor, greenhouse and indoor grown flower was 50 pounds, 22.5 pounds and 20 pounds, respectively. " ENDE Zitat
Source:https://www.cannabisbenchmarks.com/weekly-report.html
13.11.2016 08:01
RuMaS Marktbericht
Das Interesse der Trader, Anleger und Investoren an bestimmten Aktien zeigt sich an der Anzahl der Umsätze und der Zahl der damit verbundenen Preisstellungen. Eine hohe Nachfrage spricht für starke Kursbewegungen, die manchmal überzogen sein können. An den folgenden Tagen gibt es oft interessante Einstiegsmöglichkeiten.
Die meistgehandelten Auslandsaktien der Börse Stuttgart gemessen an der Zahl der Preisfeststellungen im Zeitraum vom: 03.11. bis 09.11.2016.
Rang
Auslandsaktie
WKN
Preisstellungen
1
General Cannabis
A14VV9
466
2
Cannabis Science
A0RM6Z
412
3
Apple Computer
865985
308
4
American Cannabis
A12DK9
294
5
Barrick Gold
870450
270
6
Nvidia Corp
918422
262
7
Nestle NA
A0Q4DC
248
8
Royal Dutch Shell
A0D94M
230
9
Novartis NA
904278
228
10
Millenium Lithium
A2AMUE
222
Zitat:"A single sentence in President-elect Donald Trump's health-care platform sends a strong hint to the drug and medical device industry that they may have an easier time getting their products on the market under his administration. “Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products,” his health plan states."ENDE Zitat Source:https://www.yahoo.com/news/m/...ss_trump-just-dropped-a-big-hint.html
Seit Freitag (0,49€) immerhin nun in Stuttgart um fast 150% gestiegen und liegt nur noch gut 30% unter dem Vorwochenhoch von 1,846€!
Das sind doch mal gute Aussichten....
Hatte letzte Woche auch nochmal bei 0,748€ (zuvor bei 1,01€ eingedeckt gehabt) nachgelegt, habe jetzt 4.500 St., sodass hier ein guter 4-Stelliger Gewinn (vl auch 5-stellig) möglich sein wird (n.m.M.)
Re: None
Post # of 12739
§
No way Trump lets MJ overwhelm his agenda
http://abovethelaw.com/2016/11/icymi-trump-is-marijuanas-wildcard/
Christie’s chances of becoming attorney general, however, are hampered by the “Bridgegate” scandal and bad blood between him and Jared Kushner, Trump’s son-in-law (for having prosecuted Kushner’s father). Recent reports are that Christie has been pushed out of Trump’s inner circle. Christie as attorney general is a scary proposition, but it is looking less likely.
Even if Trump appoints an anti-marijuana zealot to the attorney general post, it isn’t clear we will see a change in federal policy. Public approval of marijuana is starting to really solidify. Marijuana laws were approved in 8/9 states, including heavily Republican states. A majority of Americans now live in places that have decriminalized or legalized medical or recreational marijuana. If Trump’s Department of Justice started going after marijuana businesses in legal states, the backlash would be swift and furious, and it would threaten to overwhelm the rest of his agenda.
Further, Congress still has a role here. In the past few federal spending bills, Congress has ruled that the Department of Justice could not use federal money to interfere with state marijuana laws. The Ninth Circuit has ruled that this budget rider prohibits the Department of Justice from spending money on prosecutions if the defendants are fully compliant with state cannabis laws. This budget rider does not protect recreational cannabis businesses, which adds complications for Washington and Colorado, both of which have at least partially merged their medical and recreational marijuana programs. Even if the Department of Justice wants to crack down on marijuana businesses, it’s not clear it has the legal right to do so.
At this point, there are no clear answers on how the Trump administration will deal with cannabis, but no matter what happens, it is vital that the legalization community stay involved and stay loud. Public opinion really does matter and public officials don’t like their agendas to be dragged down by single issues. Organized cannabis lobbying is more important than ever, so keep letting your elected officials know where you stand.
Let's keep this train a rollin' AMMJ!!!
Zitat:"The Globe and Mail reports in its Tuesday edition that Canada's medical-cannabis companies say their American counterparts will continue to be stifled under the upcoming Trump presidency.....Mr. Trump has said he is "100 per cent" in favour of medical marijuana. However, even if a Republican-dominated government reclassifies cannabis, firms would likely face years meeting a host of strict regulatory hurdles from the U.S. Food and Drug Administration before they can sell it as a medicine across the country. " ENDE Zitat
Source:http://www.stockwatch.com/News/...2421744&symbol=OGI®ion=C
aus dem google-deutsch:
1.25 / 1.29 (5100 x 300)
hat nix zu sagen sieht halt schön aus....
lg Gaertner
Wir hatten immerhin gestern 40 % + gemacht.
Wo befindet sich der RSI im Moment ?
Mit welchen Kurszielen sind Ihr hier am Start ?
Bin noch am Überlegen, ob ich einen Einstieg wagen soll
LG vergeigt